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Summary
The final step in mycolic acid biosynthesis in Mycobacterium tuberculosis is catalysed by a 
mycolyl reductase encoded by the Rv2509 gene. Sequence analysis and homology modelling 
indicates that Rv2509 belongs to the short-chain fatty acid dehydrogenase/reductase (SDR) 
family, but with some distinct features that warrant its classification as belonging to a novel family 
of short-chain dehydrogenases. In particular, the predicted structure revealed a unique α-helical C-
terminal region which we demonstrated to be essential for Rv2509 function, though this region did 
not seem to play any role in protein stabilisation or oligomerisation. We also show that unlike the 
M. smegmatis homologue which was not essential for growth, Rv2509 was an essential gene in 
slow growing mycobacteria. A knockdown strain of the BCG2529, the Rv2509 homologue in 
Mycobacterium bovis BCG was unable to survive following conditional depletion of BCG2529. 
This conditional depletion also led to a reduction of mature mycolic acid production and 
accumulation of intermediates derived from 3-oxo-mycolate precursors. Our studies demonstrate 
novel features of the mycolyl reductase Rv2509 and outline its role in mycobacterial growth, 
highlighting its potential as a new target for therapies.
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Introduction
The cell walls of mycobacteria including the tuberculosis-causing Mycobacterium tuberculosis 
contain distinct long chain fatty acids termed mycolic acids. These -alkyl, -hydroxy fatty acids 
form an integral part of the cell wall of mycobacteria, and of other related bacteria of the suborder 
Corynebacterianeae, including the genera Nocardia, Corynebacterium and Rhodococcus 
(Marrakchi et al., 2014). Mycolic acids can be found covalently-linked to cell wall arabino-
galactan, and as part of the glycolipids trehalose monomycolate (TMM), trehalose dimycolate 
(TDM) and glucose monomycolate. They are essential for mycobacterial viability (Marrakchi et A
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al., 2014, Nataraj et al., 2015) and virulence and are synthesised by a complex array of enzymes 
that includes a mammalian-like Fatty Acid Synthase I (FAS-I), and a multienzyme complex of 
Fatty Acid Synthase-II (FAS-II) (Marrakchi et al., 2014). One of the late stages of mycolic acid 
biosynthesis involves the Claisen condensation of a FAS-II-derived long meromycolate chain 
(C42-C62) with a short FAS-I-derived fatty acid (C24-C26) to yield an -alkyl, -keto fatty acid 
intermediate, catalysed by the polyketide synthase Pks13 (Gande et al., 2004, Portevin et al., 
2004). The final step in the formation of a mature mycolic acid involves the enzymatic reduction 
of the β-keto group of the product of Pks13 to produce a -alkyl, -hydroxy fatty acid (mature 
mycolic acid). In M. tuberculosis, the reductase required for this final step is encoded by Rv2509 
(Bhatt et al., 2008, Lea-Smith et al., 2007). Initial studies in Corynebacterium glutamicum, a 
species that can survive loss of mycolic acids, indicated that deletion of cmrA (NCgl2385), the 
Rv2509 orthologue, resulted in a strain that accumulated the -alkyl, -keto fatty acid precursor 
instead of mature mycolic acids (Lea-Smith et al., 2007). Mycolic acid biosynthesis genes are 
essential in mycobacteria; however, surprisingly, we were able to generate a viable mutant of 
MSMEG4722, the homologue of Rv2509 in the fast growing Mycobacterium smegmatis (Bhatt et 
al., 2008). Similar to the C. glutamicum NCgl2385 mutant, the M. smegmatis MSMEG4722 
mutant produced -alkyl, -keto fatty acyl precursors of mycolic acids (3-oxo-mycolic acid 
precursors) which were transported and esterified to the arabinogalacatan in the cell wall (Bhatt et 
al., 2008). While the precise knowledge of the substrate for Rv2509 is lacking, functional analysis 
of the preceding enzyme in the biosynthetic pathway, Pks13, indicated that while this polyketide 
synthase primarily catalyses the formation of the -alkyl, -keto fatty acyl precursor, it also 
contains enzymatic motifs that facilitate the release of the nascent fatty acyl chain and its 
subsequent transfer to a trehalose residue to produce a trehalose residue esterified with the -
alkyl, -keto fatty acyl precursor of mycolic acid (Gavalda et al., 2014). These findings suggest 
that the trehalose-bound mono 3-oxo-mycolic acid precursor may likely be the substrate for 
Rv2509, which catalyses its conversion to trehalose monomycolate (Fig.1). In this study we set 
out to do a detailed study of the amino acid sequence of Rv2509 with the aim of deducing its 
structure and functional connections, which led to the identification of series of unique sequences, 
and by proxy, novel structural features. We then probed the role of one distinct structural feature 
of the mycobacterial mycolyl reductase in vitro by deletion analysis. We also probed the 
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essentiality of Rv2509 for growth and viability of the slow growing M. tuberculosis complex using 
Mycobacterium bovis BCG.
Results
Homologues of M. tuberculosis Rv2509 are found across mycolic acid-producing species.
While mycolic acids are produced by a number of species belonging to the suborder 
Corynebacterineae, the biosynthesis of mycolates has been studied in detail exclusively in the 
genera Mycobacterium and Corynebacterium. While the two genera share a common set of 
enzymes required for mycolic acid biosynthesis, select differences also exists. For example, while 
the meromycolate chains are synthesised by a Type-II fatty acid synthase complex in species of 
Mycobacterium, the same function is carried out by a mammalian-like Type-I fatty acid synthase 
in Corynebacterium species (Radmacher et al., 2005). Similarly, differences exist in the transport 
of mycolic acids between the two genera (Varela et al., 2012, Yang et al., 2014). To investigate 
whether the reduction of premycolates by an exclusive mycolyl reductase, was an enzymatic 
process conserved across other mycolic acid producing species, we used the amino acid sequence 
of Rv2509 as a source template for a BLASTp search of genome sequences of other known 
mycolic acid-producing bacteria. Homologues of Rv2509 were found across the mycolate-
producing genera (Fig.2). A phylogenetic analysis of Rv2509, its homologues in other 
mycobacteria and in select mycolic acid producing species revealed that mycolyl reductases from 
corynebacterial species branched early (Supporting Information Fig.1). Corynebacteria produce 
relatively short chain mycolic acids (Radmacher et al., 2005). To test whether mycolyl reductases 
across the mycolata had evolved specificities to accommodate differing chain lengths, we 
transformed the M. smegmatis MSMEG4722 strain with a plasmid containing C. glutamicum 
mycolyl reductase gene NCgl2385 to generate the strain ΔMSMEG4722-CNCgl2385. Mature 
mycolic acid production was restored in the transformed strain indicating that NCgl2385 could A
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reduce M. smegmatis 3-oxo-mycolic acid precursors and consequently fully complement the 
mutant M. smegmatis strain. This outcome suggested that mycolyl reductases across the mycolata 
likely did not evolve specificities for differing chain lengths (Fig.3).
Predicted structure of M. tuberculosis Rv2509
We attempted to deduce possible functional properties of Rv2509 using a comparative sequence 
and structural analysis with proteins of known function. Sequence analysis of Rv2509 using the 
NCBI conserved domain database (Marchler-Bauer et al., 2015) categorises the protein as a part 
of the DltE family of short-chain dehydrogenases (cluster COG0300), which are in turn members 
of the cl27753 short-chain dehydrogenase/reductase (SDR) superfamily of NAD(P)-dependent 
oxidoreductases. This is a diverse group, containing over 80,000 unique sequences (Fujisawa et 
al., 2003). However, despite this diversity, all SDR-superfamilies display the classical Rossmann 
fold typical of NAD+/NADP+-binding proteins and hence can be classified as belonging to the 
cl21454 family of topologically and structurally related proteins.
Next, we screened the peptide sequence of Rv2509 against the PDB database to find 
structural templates for homology modelling. The serine dehydrogenase YdfG (Uniprot ID 
P39831; PDB ID 3ASU/3ASV) (Yamazawa et al., 2011), had the highest identity score, however 
structural analysis revealed several gaps in the pairwise alignment, and the C-terminal region was 
shorter than that observed in Rv2509, which necessitated additional template input. Therefore, the 
structures of the four highest-scoring experimental SDRs (3ASU/3ASV, 1XG5, 4X54 and 4BMV) 
were used in parallel as a basis for comparative homology modelling of Rv2509 (Fig.4) using the 
I-TASSER package (Yang et al., 2015) with specific template selection enabled. Notably, while, 
three of the templates yielded models with roughly equivalent (confidence) C-scores, the one 
based on the SDR from Sphingobium yanoikuyae (4BMV.pdb; GenBank ID ACB78183.1) stood 
out with the highest C-score of 0.6, indicating high quality of prediction. 
As visualized by the structural alignment (Fig.2) which shows the predicted secondary 
structure elements of Rv2509 aligned to its corynebacterial homologues, the core structure of the 
Rv2509 model presents a typical NADP-binding protein Rossmann fold (residues 1-235) (Persson 
et al., 2003) with 7 parallel β-strands forming a central β-sheet, which is sandwiched between two 
layers of α-helices – three on each side (Fig. 4). Although an earlier study has correctly classified 
Rv2509 within the short-chain reductase (SDR) superfamily and identified crucial sequence 
signatures such as the potential NAD(H)/NADP(H) binding motif and active site in residues 157-A
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161 (Lea-Smith et al., 2007), it did not include further structural prediction and analysis, and was 
limited in terms of sequences used. We therefore sought to expand of this initial analysis by 
performing a systematic analysis of the Rv2509 orthologues from a wide range of 
Corynebacterineae, so as to represent all known mycolate-producing genera. 
We initiated these studies by analysing the co-factor binding site. SDRs can be divided into 
two large families, ‘Classical’ SDRs which are around 250 amino acid residues long and 
‘Extended’ SDRs which contain around 350 residues (Jornvall et al., 1995), exhibiting differences 
in the arrangement of glycine residues within the co-enzyme binding sites. Coenzyme preference-
predictions based on the strong conservation of the signature residues (Persson et al., 2003) 
classified the Rv2509 into the group of the NADP(H)-binding SDRs, consistent with its mycolyl 
reductase function. However, it was difficult to categorically allocate Rv2509 into a specific group 
of SDRs as the predicted NADP-binding site of Rv2509 (G16XXQ19N20I21G22) displays a unique 
and novel variation of the (T)-G-X-X-X-G-I-G motif described by Brakoulias and Jackson 
(Brakoulias & Jackson, 2004) (Fig.2). The variation seems to be restricted to the long-chain 
mycolate producing species of Mycobacteriaceae, as short chain mycolate producing 
Corynebacteria retain the more established G-X-X-X-G-I-G motif. (Fig.2). Key residue positions 
in the NADP(H) site suggest Rv2509 is a cP2 member of the “Classic” SDR family, according to 
the classification system of Persson et al., (Brakoulias & Jackson, 2004), which is further 
reinforced by the presence of two specific discriminator residues, R-R, found in positions 41-42 in 
both Rv2509 and YdfG from E. coli (3ASV.pdb), as these residues are associated with 
coordination of the phosphate group of the NADP(H) cofactor. Further analysis of Rv2509 
suggests that has a Class IV NADP(H) binding site (with consensus [AVIC]-[LIV]-[VIL]-T-G-
[ASGC]-X2-[GR]-[ILF]-G-X6-[LFY] (Hua et al., 2014). Thus, our analysis firmly places the 
Rv2509 family within the NADP(H) binding sub-family of SDRs.
The active site in SDRs is formed by a tight cleft, lined by α-helix 4, β-strand 4 and α-helix 
5 (Filling et al., 2002, Oppermann et al., 1997). Rv2509 exhibits the “classical” SDR motif 
Yx[AS][ST]K in α-helix 5 (Y157 and K161 being the central catalytic residues), while the 
GxggxgSS/T motif in β-strand 4 (G137, S144) and the central residue of α-helix 4, N116 (Fig.2) 
are also instantly recognisable. In addition, it is possible that some contact with the substrate may 
be provided by the β-strand 4. 
Rather intriguingly, the consensus residues ‘NNAG’ involved in the stabilization of the 
central -sheet of the Rossmann fold in the “Classical” SDRs and located at the core of the A
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protein, are not fully conserved in Rv2509, but take the form of a novel ‘ANAG’ sequence (see 
Fig.2). Furthermore, this novel sequence is paired with a preceding Cys residue, which is also 
correlated with the presence of a C-terminal Thr (in position 91 in M. tuberculosis). This unique 
‘CANAGT’ signature makes Rv2509 orthologues in Mycobacteriaceae instantly recognisable 
(Fig.2).
In SDR proteins, the substrate binding loop links the sixth β-sheet with the seventh α-helix, 
and is one of the larger loops. In the predicted structure of Rv2509 this loop spans roughly from 
P187 to S214 and appears largely conserved within the mycolic acid producing species (Fig.2). 
While the loop’s length and position corresponds closely to the length of the substrate binding 
loop in both 4BMV (P183-E206); and 3ASV (P178-T208), there was little conservation of the 
loop’s sequence relative to Rv2509 in these and other divergent SDRs (see Consurf analysis below 
(Ashkenazy et al., 2016); Supporting information Fig.2), suggesting, as expected, major 
differences in the structure of the substrate for Rv2509.
The most intriguing finding upon the analysis of the Rv2509 orthologues was that all of 
them seem to present a C-terminal domain which seems to be highly specific to the 
Corynebacterineae. It proved also the most difficult to model reliably, as in the majority of the 
available SDR structural templates, the C-terminal region, appears to be either truncated or 
disorganized. ConSurf mapping using the multiple sequence alignment shown in Fig. 2 and 
multiple sequence alignment based on 150 non-redundant sequences of remote SDR homologues 
revealed that C-terminus of Rv2509 is uniquely a feature of the subfamily of Corynebacteriales 
(Supporting information Fig.3). Both pairwise and multiple sequence analyses indicated that the 
C-terminal region of the 4BMV.pdb is the closest related to Rv2509 and thus can be tentatively 
used as a template for that region. This was further corroborated that by comparative modelling 
(Song et al., 2013) and pure ab-initio modelling (Raman et al., 2009), as implemented in the 
NewRobetta server (http://new.robetta.org). To validate this hypothesis, we conducted additional 
ab initio secondary structure predictions of Rv2509 (236-268) using JPred4 (Drozdetskiy et al., 
2015) and PSIPRED (Jones, 1999; Buchan and Jones, 2019) Both of these bioinformatics tools 
supported a high alpha-helical propensity of the C-terminal region of Rv2509, suggesting that 
4BMV as a reliable template for the region (Supporting information Fig.3). Indeed, the C-terminus 
of the 4BMV.pdb structure, similarly to Rv2509, appears to be extended and is well-structured, 
presenting an α-helical organisation.
The extended C-terminal of Rv2509 is essential for functionA
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Mature mycolic acid production could be restored in the M. smegmatis MSMEG4722 mutant on 
complementation with the M. tuberculosis orthologue Rv2509 (Bhatt et al., 2008). The mutant 
strain thus provided us with a means of identifying residues and domains required for Rv2509 
function, by assessing the ability of mutated constructs of plasmid-borne Rv2509 to complement 
the MSMEG4722 strain by restoring mature mycolic acid biosynthesis. To test if the extended C-
terminal of Rv2509 was required for function, we generated truncated versions of Rv2509 cloned 
in the replicative shuttle plasmid pMV261 (Stover et al., 1991). Individual plasmids were then 
introduced by electroporation into the M. smegmatis MSMEG4722 mutant and the transformed 
strain analysed for restoration of mature mycolic acid biosynthesis. Deletion of 14 amino acid 
residues (Ala255-Ser268) from the C-terminal of Rv2509 resulted in a complete loss of function as 
the strains transformed with the truncated construct failed to restore mature mycolic acid 
biosynthesis in the MSMEG4722 strain (Fig.5; MSMEG4722-CRvD1). A construct with a 
shorter truncation (Tyr262-Ser268 deleted) also failed to complement the MSMEG4722 strain 
(Fig.5; MSMEG4722-CRvD2).  Expression of Rv2509 and truncated constructs could be detected 
by RT-PCR confirming that the loss of Rv2509 function was linked to deletion of the C-terminal 
residues (Supporting Information Fig.4). These results demonstrated that the C-terminus of 
Rv2509 spanning terminal residues Ala255-Ser268 was critical for function. The findings suggested 
an essential role for the unique, C-terminal extension in the activity of Rv2509.
To further query whether this C-terminal extension played a role in either protein stability, 
protecting Rv2509 from degradation, or in oligomerisation, we expressed N-terminal His-tagged 
versions of Rv2509 and Rv2509-D1 (Rv2509 with Ala255-Ser268 deleted) in Escherichia coli. 
Western blot analysis of native polyacrylamide gels showed there were no patterns of degradation 
detected in Rv2509-D1 indicating that the loss of function due to the deletion of this region was 
not related to protein stability (Supporting Information Fig.5). Furthermore, we did not observe 
additional slower migrating bands indicating dimerization (or oligomerisation) of full length or 
truncated Rv2509. Furthermore, crosslinking Rv2509 with glutaraldehyde did not reveal 
additional slower migrating bands suggesting that Rv2509 did not oligomerise in solution 
(Supporting Information Fig.5).
Rv2509 is an essential mycobacterial gene
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Given the non-essentiality of the mycolyl reductase gene in M. smegmatis, and prediction of 
transposon-site hybridisation screens of a slow growing M. tuberculosis Rv2509 mutant, we aimed 
to generate a null mutant of Rv2509 in M. tuberculosis using Specialized Transduction (Bardarov 
et al., 2002). Such a mutant would also allow us to test the role of the mycolyl reductase in 
virulence using macrophage and mouse models of infection. However, repeated attempts failed to 
generate transductants, suggesting that Rv2509 was essential for growth in M. tuberculosis. 
Indeed, subsequent transposon mutagenesis screens utilising deep sequencing predicted Rv2509 to 
be essential for in vitro growth of M. tuberculosis (Griffin et al., 2011). We then utilised a 
promoter replacement strategy to demonstrate the essentiality of Rv2509 in slow growing 
mycobacterial vaccine strain Mycobacterium bovis BCG. The Pmyc1 promoter from M. smegmatis 
engineered to contain four tetO operator sites (Korte et al., 2016) was inserted immediately 
upstream of the start codon of BCG2529, the Rv2509 homologue in M. bovis BCG-Pasteur, using 
Specialised Transduction generating the strain BCG::PTet-Mb2537. Controlled gene expression of 
the BCG2529 gene was achieved using a plasmid borne synthetic gene (rev-tetR) derived from 
Tn10 tetR encoding a mutated TetR protein with reversed binding affinity to tetO sites upon 
binding of tetracycline. Addition of anhydrotetracylcine (ATc) results in loss of expression.
Addition of ATc resulted in loss of growth of BCG::PTet-BCG2529 in broth indicating that 
expression of the gene encoding the mycolyl reductase was essential for in vitro growth of slow 
growing mycobacteria (Fig.6A). Furthermore, while concentrated cultures of BCG::PTet-BCG2529 
showed confluent growth on 7H10 agar plates, no confluent growth was observed on plates 
containing ATc (Fig.6B). We did observe a few scattered colonies on the ATc-containing plates 
and these are likely to be supressors allowing leaky expression of PTet driven BCG2529. These 
results demonstrated that the mycolyl reductase was essential for growth and viability of slow 
growing mycobacteria.
Conditional depletion of the mycolyl reductase results in loss of mature mycolic acids
The M. smegmatis mycolyl reductase mutant was unable to synthesise fully mature mycolic acids, 
and instead produced 3-oxo-mycolate precursors that were found esterified to the cell wall 
arabinogalactan and to trehalose (Bhatt et al., 2008). These labile precursors gave rise to 
palmitone derivatives following alkali treatment, which were visualised on Thin Layer 
Chromatography (TLC) plates migrating close to the solvent front in a solvent system used for 
separating methyl esters of mycolic acids and fatty acids (FAMEs and MAMEs) (Bhatt et al., A
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2008). To test the effects of conditional depletion of the mycolyl reductase we labelled cultures of 
BCG::PTet-BCG2529 with 14[C]-acetic acid following grown in the presence and absence of ATc, 
and extracted MAMEs from the cultures. TLC analysis of the extracted MAMES showed a 
decrease in the levels of  and keto MAMES, and an accumulation of the degradation products 
derived from 3-oxo-mycolate precursors close to the solvent front (Fig.7). These results showed 
that, as in M. smegmatis, loss of the mycolyl reductase function led to the loss of mature mycolic 
acid production and accumulation of the premature 3-oxo-mycolate precursors in slow grow 
mycobacteria.
Discussion
As summarised above, the predicted structure of the Rv2509 displays a Rossmann fold with 7 
parallel β-strands forming a central beta-sheet, which is sandwiched between two layers of alpha-
helices – three on each side (Fig. 4). While largely consistent with the “classical” family of SDRs 
(Persson et al., 2003), in Mycobacteriaceae, the NADP(H) binding motif (G-x-x-Q-N-I-G), 
alongside the core stabilisation consensus (C-A-N-A-G-T) are significantly divergent from the 
consensus, to instantly identify this group of SDRs, and in our view is distinct enough to be 
separated into a distinct family. 
While we currently lack knowledge about the exact mode of co-factor and ligand binding 
within the Rv2509 family, some information could be inferred from the structurally related FabG 
family of β-ketoacyl reductases which are classified as ‘Complex family SDRs’ (Persson et al., 
2003). Given that the structural overlay of Rv2509 models with existing ligand-bound FabG 
members yields an RMSD of around 1 Å over the C-alpha backbone atoms, and that FabG share 
common active site residues with Rv2509 it is tempting to suggest that these structures share 
common ligand-binding and NADP(H) orientations towards the active site residues with that 
observed in the aceto-acyl-CoAs. Furthermore, the predicted 3D structure of Rv2509 also revealed 
a unique -helical C-terminal extension, which we subsequently showed to be essential for 
function - constructs with deletions in the C-terminal failed to complement (restore mycolate 
biosynthesis) in the M. smegmatis mutant.
The role of this C-terminal domain is difficult to assign with certainty, however in related 
SDRs similar C-terminal extensions play a number of functions. In the NADP(H)-dependent 
tetrameric serine-dehydrogenase YdfG from E.coli (3ASV.pdb) (Yamazawa et al., 2011), the C-
terminal region protrudes from the main core of the protein and is required for tetramer formation A
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also plays a role in the substrate binding via stabilisation of the substrate loop. It is also notable 
that in FabG family of related SDRs (see below) also organise as tetrameric assemblies with the 
participation of their C-terminal domains (Javidpour et al., 2014). Furthermore, in the 
mycobacterial FabG4 dimer, Arg146 and Arg445 of one protomer interact with the C-terminus of 
the second protomer and play an essential role in substrate association and catalysis (Dutta et al., 
2013). However, our experiments with purified full length and truncated Rv2509 do not seem to 
suggest that the mycolyl reductase forms oligomers.
While it isn’t in itself surprising that Rv2509 presents a conserved SDR fold, our analysis 
has identified it for the first time decisively as a member of the NADPH-binding family and 
indicated that it possesses a number of unique features. Taken together the unique signatures of 
the NADPH-binding site, core stabilisation domains, as well as C-terminal domain extension 
possibly merit its inclusion into a distinct family.
Our previous studies with M. smegmatis suggested that the mycolyl reductase would likely 
not be essential for growth in M. tuberculosis and related slow-growing mycobacteria. However, 
this work demonstrated that gene encoding the reductase, Rv2509, was an essential gene required 
for growth of slow growing mycobacteria in laboratory media. This, along with the identification 
of unique domains in the predicted structure of Rv2509 highlights its potential as a novel anti-TB 
drug target.
Experimental Procedures
Growth conditions, strains, phages and plasmids
M. smegmatis mc2155 and derived strains was cultured in Tryptic Soy Broth (TSB) or on TSB-
agar, M. bovis BCG strains were grown in 7H9 broth or on 7H10 agar plates. Escherichia coli 
strains were grown in LB broth or LB agar. Hygromycin was used at a concentration of 100 mg 
ml-1 for E. coli and for mycobacterial strains. Kanamycin was used at a concentration of 25 mg ml-
1 and 50 mg ml-1 for mycobacteria and E. coli respectively. Recombinant mycobacterial strains, 
phages and plasmid constructs used in this study listed and described in Table.1.
Sequence analysis and homology modelling
The multiple sequence alignments (MSA) were prepared using MAFFT and NJ/UPGMA 
phylogeny algorithms as implemented in MAFFT v.7 server (https://mafft.cbrc.jp/ (Katoh et al., A
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2002)) and the resulting phylogenetic trees were visualized using Archaeopteryx (Han & Zmasek, 
2009). Multiple sequence alignment visualisation and structural annotations were performed using 
Espript 3 (Gouet et al., 2003). For the purposes of homology modelling, we employed I-TASSER 
(Yang et al., 2015) with assignment of templates. Outputs were independently corroborated by ab-
initio modelling using the NewRobetta server (http://new.robetta.org). Sequence conservation 
analysis was done using ConSurf (Ashkenazy et al., 2016) and visualised using Pymol (The 
PyMOL Molecular Graphics System, Version 1.71 Schrödinger, LLC) with additional local 
manual refinement and structural superposition performed in Coot (Emsley et al., 2010). 
Secondary structure predictions for the C-terminal domain performed with JPred4 (Cole et al., 
2008) and PSIPRED (Buchan et al., 2013). 
Expression, purification and analysis of Rv2509 and its C-terminal truncated derivative
Rv2509 was cloned in the expression vector pET28a by PCR from M. tuberculosis H37Rv 
genomic DNA using the primer pair Pet28a_Rv2509 _F2 (5’-TTTACATATGCCGATA 
CCCGCGCCC-3’) and Pet28a_Rv2509_R1 (5’-ATTAAAGCTTCTAGCTGCCCCCAA 
GCCTCTTG-3’). Similarly, the C-terminal truncated version of Rv2509 (missing the last 14 
amino acids) was PCR amplified using the primer pair Pet28a_Rv2509 _F2 (5’-TTTACATA 
TGCCGATACCCGCGCCC-3’) and Pet28a_Rv2509_delR1 (5’-ATTAAAGCTTCTACA 
CGATGGCGCGCGGAGC-3’). The constructs were co-transformed into BL21 cells with M. 
tuberculosis chaperone GroES 60.2. Cultures were seeded 1:100 with an overnight starter culture 
and grown at 37°C in terrific broth supplemented with ampicillin (100µg/mL) and kanamycin 
(50µg/mL) to OD600 = 0.6 and induced with 0.5mM IPTG overnight at 37°C or 16°C 
respectively. Cells were harvested at 4,000rpm at 4°C, washed with PBS and frozen at -80°C until 
further use. Full length protein was purified on cobalt-IMAC in buffer 50mM NAH2PO4 pH 7.5, 
500mM NaCl, 10% glycerol and truncated in the same buffer composition at pH 7.0. The eluted 
fraction of 200mM imidazole was taken for native-PAGE analysis.
A native polyacrylamide gel with the separated samples was transferred to a Hybond™ 
nitrocellulose membrane (GE Healthcare Life Sciences) which was then blocked in 5% milk 
20mM Tris pH7.5, 150mM NaCl TBS 0.05% Tween for 1h at room temperature followed by 
incubation with 0.1% milk TBS-tween with penta-his antibody BSA free (QIagen). Following 
washing with TBS-tween the membrane was incubated with 0.1% milk TBS-tween with anti-
mouse IgG-Alkaline Phosphatase (Sigma Aldrich) for 30 min at room temperature, washed with A
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TBS-tween and a final wash with TBS. The membrane was stained for 5 min with BCIP/NBT 
(Sigmafast™) in water for visualization.
Cross linking of full length Rv2509 was carried out in 50mM NaH2PO4 pH 7.5, 10% 
glycerol at final concentration of 0.1% glutaraldehyde and allowed to progress at room 
temperature for 2 minutes. The reaction was halted with 1M Tris pH 8 and subsequently run on 
SDS-PAGE for visualisation using SYPRO-ruby (Molecular Probes). 
Conditional depletion of the Rv2509 homologue BCG2529 in M. bovis BCG-Pasteur
For establishing regulated expression of the BCG2529 gene, a synthetic gene cassette (hyg-Pmyc1-
4XtetO) comprising a hygromycin resistance gene and the Pmyc1 promoter from M. smegmatis 
engineered to contain four tetO operator sites (Korte et al., 2016) was inserted immediately 
upstream of the BCG2529 start codon in M. bovis BCG-Pasteur. Targeted gene knock-in was 
achieved by specialized transduction employing temperature-sensitive mycobacteriophages 
essentially as described previously (Korte et al., 2016). Briefly, for generation of an allelic 
exchange construct for site-specific insertion of the hyg-Pmyc1-4XtetO cassette in M. bovis BCG-
Pasteur, upstream- and downstream DNA regions flanking the BCG2529 start codon were 
amplified by PCR employing the oligonucleotide pairs Mb2537_LL 5´-
TTTTTCCATAAATTGGAACCGCTACCTGACATGAAACCC-3´ and Mb2537_LR 5´-
TTTTTCCATTTCTTGGGCCGATGTTCTGCGAAGCCCCGG-3´ as well as Mb2537_RL 5´-
TTTTTCCATAGATTGGATGCCGATACCCGCGCCCAGCCC-3´ and Mb2537_RR 5´-
TTTTTCCATCTTTTGGCGGTGTGGGAGGAGATACTCAAG-3´, respectively. The gene 
BCG2528c is localized in antilinear orientation upstream of BCG2529 with only 84 bp between 
the start codons of both genes. Since it thus could not be excluded that the Mb2536c promoter 
region might overlap with the BCG2529 coding region, the upstream flanking region contained a 
duplication of 66 bp of the 5´-end of BCG2529 to conserve 150 bp in front of BCG2529 that likely 
comprised its promoter. Subsequently, the upstream and downstream flanks were digested with 
Van91I (restriction sites underlined), and ligated with Van91I-digested pcRv1327c-4XtetO vector 
arms (Korte et al., 2016). The resulting knock-in plasmid was then linearized with PacI and 
cloned and packaged into the temperature-sensitive phage phAE159 (Jain et al., 2014), yielding a 
knock-in phage which was propagated in M. smegmatis at 30°C. Allelic exchange in M. bovis 
BCG-Pasteur using the knock-in phage at the non-permissive temperature of 37°C was achieved 
by specialized transduction using hygromycin (50 mg/l) for selection, resulting in site-specific A
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insertion of the hyg-Pmyc1-4XtetO cassette. The obtained M. bovis c-BCG_2529-4XtetO knock-in 
mutant was verified by diagnostic PCR of genomic DNA using the oligonucleotide pair 
BCG_2529_L_fw 5´ GTCAGGTAGACGGAGAACAC-3´ and BCG_2529_L_rev 5´ 
AGCTCACCGCGCAGAGATTC-3´ binding outside the allelic exchange substrates used to 
generate this mutant and subsequent sequencing of PCR products (Supporting Information Fig.6).
For achieving controlled gene expression of the Mb2537 gene, a synthetic gene (rev-tetR) 
derived from Tn10 tetR encoding a mutated TetR protein with reversed binding affinity to tetO 
sites upon binding of tetracycline (Klotzsche et al., 2009) was heterologously expressed in the 
knock-in mutant by electroporation of the episomal E. coli-mycobacterium shuttle plasmid 
pMV261::rev-tetR-RBS-D providing constitutive rev-tetR gene expression from the HSP60 
promoter in mycobacteria using solid medium containing 50 mg/l hygromycin and 20 mg/l 
kanamycin for selection (Famulla et al., 2016). This yielded the conditional mutant BCG-Pasteur 
c- BCG2529-4×tetO pMV261::rev-tetR-RBS-D (referred to as BCG::PTet- BCG2529) allowing 
silencing of the BCG2529 gene in presence of anhydrotetracycline (ATc).
For silencing experiments, precultures of the BCG::PTet- BCG2529 strain were first grown 
in liquid medium containing 0.3 µg/ml ATc, before these precultures were used to inoculate test 
cultures containing 0 - 5 µg/ml ATc. Growth in 96-well microtiter plates was quantified after 
incubation at 37°C for five days by adding 10% of a 100 µg/mL resazurin solution. After further 
incubation at ambient temperature for 16 h, cells were fixed for 30 min by formalin addition (5%, 
v/v, final concentration), and fluorescence was quantified using a microplate reader (excitation 
540 nm, emission 590 nm). For growth on 7H10 agar, non-permissive conditions were obtained by 
adding ATc to a final concentration of 5 µg/ml.
Functional complementation studies
Deletion constructs for Rv2509 were generated by PCR amplification of selected regions of 
Rv2509 using pMV261-Rv2509 as a template, incorporating a premature stop codon in the reverse 
primer. The plasmid constructs generated in this manner were called pMV261-Rv2509D1 and 
pMV261-Rv2509D2, encoding a truncated protein missing the C-terminal residues Ala255-Ser268 
and Tyr262-Ser268 respectively.  The C. glutamicum Rv2509 orthologue, NCgl2385 was PCR 
amplified using C. glutamicum genomic DNA as a template and the PCR product was cloned into 
pMV261 using primer incorporated BamHI and EcoRI sites generating the plasmid pMV261-
NCgl2385.  Plasmid clones were electroporated into the M. smegmatis MSMEG4722 mutant A
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strain using previously described protocols (Snapper et al., 1990). Kanamycin resistant 
transformants were cultured in TSB and FAMEs and MAMEs were extracted from the cell pellets 
and separated by TLC as previously described (Vilcheze & Jacobs, 2007).
RT-PCR of Rv2509 transcripts
M. smegmatis strains were grown to mid-log phase, and RNA was extracted by acid phenol and 
chloroform extraction. The purified RNA was treated with DNase and converted to cDNA, which 
was used as a template for quantitative PCR. PCR products were run on a 1% agarose gel to detect 
the expression of Rv2509. The gene sigA was monitored as a constitutively expressed gene. The 
primers used for PCR amplification were Rv2509RT-f (5’-ACAAGTACCGCGTCACGGTC -3’) 
and Rv2509RT-r (5’-AAGTCCGGCACC AGCTTCTC-3’) for amplification of non-deleted 
sections of Rv2509.
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Abbreviated Summary
The Mycobacterium tuberculosis gene Rv2509 encodes a reductase enzyme involved in the last 
step of synthesis of mycolic acids, a key cell wall lipid. By generating a predicted model for the 
protein encoded by Rv2509, we show that the enzyme has distinct structural motifs including a 
distinct C-terminal region, which we show by complementation studies to be vital for function. 
The gene is also essential for growth and viability underlining its potential as a new drug target.
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Figure Legends
Fig.1 Proposed reaction catalysed by Rv2509. The putative substrate is trehalose mono-
premycolate and the product is trehalose monomycolate. The examples shown here is that of an -
mycolic acid from M. tuberculosis.
Fig.2 A structural alignment of the predicted Rv2509 structure from M. tuberculosis, with 
annotated secondary structure elements (top) with the sequences of the Mycobacterial and 
Corynebacterial homologues highlighting the unique sequence motifs of the Rv2509 subfamily of 
SDRs. The GxxQNIG motif along with RR pair identifies a novel NADP(H) binding consensus, 
limited to Mycobacteriacea (highlighted in yellow). GxxSGIG is the wider consensus seen in the 
more remotely related Corynebacteria. Similarly, the unique Rossmann core-stabilisation signature 
CANAGT reported here is also restricted to the Mycobacteriaceae (highlighted in yellow), and 
reverts to the more common (C)NNAG(I/F) in the more remote homologues. Active site residues 
N-G-S-Y-K in alpha-helix 4 and alpha-helix 5 are preserved throughout the family, however, a 
unique additional tyrosine residue can be seen to be present in Mycobacteriaceae (highlighted in 
yellow). The C-terminal extension is also uniquely conserved across the wider Corynebacterial 
species. 
Fig.3 Complementation of the M. smegmatis MSMEG4722 mutant with the corynebacterial 
mycolyl reductase. TLC analysis of 14C-labelled mycolic acid methy esters (MAMEs) isolated 
from different strains. ;  MAMEs, ´; ´ MAMEs, e; epoxy MAMEs, O; origin, D, degradation A
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products derived from 3-oxo-mycolate precursors. Solvent system; Petroleum ether:acetone (95:5, 
v:v).
Fig.4 Visualisation of the predicted structure of M. tuberculosis Rv2509 monomer. Two different 
orientations are given; side-view and top-down view towards the co-enzyme binding site. The 
protein is coloured as a rainbow from blue (N-terminus) to red (C-terminus) and main secondary 
structure elements are labelled, as well as the predicted C-terminal extension domain is circled in a 
red oval. The location of key sequence and structural motifs discussed in the text is also provided.
Fig.5 TLC analysis of 14C-labelled MAMEs isolated from strains of M. smegmatis MSMEG4722 
mutant transformed with the different deletion constructs of Rv2509. ;  MAMEs, ´; ´ 
MAMEs, e; epoxy MAMEs, O; origin, D, degradation products derived from 3-oxo-mycolate 
precursors. Solvent system; Petroleum ether:acetone (95:5, v:v).
Fig.6 Conditional depletion of the mycolyl reductase in BCG::PTet- BCG2529 leads to loss of 
growth. A; growth in different concentrations of ATc in 7H9 broth, B; growth on 7H10 agar 
containing 5 µg/ml ATc. Control strain; BCG transformed with pMV261::rev-tetR-RBS-D.
Fig.7 TLC analysis of 14C-labelled MAMEs isolated from BCG::PTet- BCG2529 strain. ;  
MAMEs, keto; keto MAMEs, O; origin, D, degradation products derived from 3-oxo-mycolate 
precursors. Solvent system; Petroleum ether:acetone (95:5, v:v).
Supporting information Fig.1
Phylogenetic analysis based on the sequences of Rv2509 homologues and showing the positions of 
some of the structural templates used for their modelling. Length of branches corresponds to 
evolutionary distance. Note the tight clustering of Mycobacteriacea Rv2509 homologues.
Supporting information Fig. 2
Consurf mapping of sequence conservation onto the predicted Rv2509 structure.
A. Mapping of conservation within the Corynebacterial sequences presented in the MSA shown in 
Figure 2, highlights the high level of conservation of both substrate loop and C-terminal extension 
indicative of preservation of functional residues associated with these structural elements. B. A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
Mapping of conservation across wider SDR family, covering 150 unique sequences from UNIREF 
database, shows that both C-terminal extension and the substrate binding loop are highly variable 
outside of the immediate corynebacterial grouping. Note that the active site residues and co-
enzyme binding residues – (deep purple in the core) are instantly recognisable and at conserved 
positions across SDR family.
Supporting information Fig. 3
Secondary structure prediction for the C-terminal domain of Rv2509 suggests strongly alpha-
helical propensity (A) Output from PSIPRED and (B) JPRED4 output incorporating JNET.
Supporting information Fig.4
Detection of Rv2509 transcripts in M. smegmatis strains transformed with C-terminal deletion 
constructs by RT-PCR. (A) shows products for Rv2509 while (B) shows products obtained for 
control (sigA).
Supporting information Fig.5
Analysis of full length and C-terminal truncated Rv2509 by Native PAGE (A) and glutaraldehyde 
crosslinking (B).  
Supporting information Fig.6
Generation of a conditional M. bovis BCG-Pasteur BCG2529 mutant.
(A) Organization of the BCG2529 locus in M. bovis BCG-Pasteur wild-type as well as in a 
BCG2529 conditional mutant. The sizes of relevant fragments as well as the location of the 
oligonucleotides used for diagnostic PCR are indicated. WT, wild-type; fw, oligonucleotid 
BCG_2529_L_fw; rev, oligonucleotid BCG_2529_L_rev; hyg, hygromycin resistance gene. (B) 
Diagnostic PCR of genomic DNA using oligonucleotides binding to the position indicated in A, 
showing the insertion of a synthetic gene cassette (hyg-Pmyc1-4XtetO) that contained a 
duplication of 66 bp of the 5´-end of BCG2529.
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Table 1. Plasmids and bacterial strains used in this study. 
 
 Description Reference/Source 
Plasmids 
pMV261 E. coli-Mycobacterium shuttle plasmid 
vector with hsp60 promoter and 
KanR cassette (aph) 
 
(Stover et al., 1991) 
pMV261-Rv2509 Rv2509 cloned in pMV261 (Bhatt et al., 2008) 
pMV261-NCgl2385 NCgl2385 cloned in pMV261 This work 
pMV261-Rv2509D1 Deletion construct of Rv2509 cloned in 
pMV261-encodes a truncated protein 
missing the C-terminal residues Ala 255-
Ser 268 
This work 
pMV261-Rv2509D2 Deletion construct of Rv2509 cloned in 
pMV261-encodes a truncated protein 
missing the C-terminal residues Tyr 262-
Ser 268 
This work 
pMV261::rev-tetR-RBS-D Episomal E. coli-mycobacterium shuttle 
plasmid pMV261::rev-tetR-RBS-D 
providing constitutive rev-tetR gene 
expression from the HSP60 promoter in 
mycobacteria 
(Korte et al., 2016) 
pET28a-Rv2509 Plasmid for expressing Rv2509 in E. 
coli 
This work 
pET28a-Rv2509D1 Plasmid for expressing C-terminal 
truncated Rv2509 in E. coli 
This work 
Bacterial strains 
mc2155 Electroporation-proficient ept mutant 
of M. smegmatis strain mc26 
(Snapper et al., 1990) 
MSMEG4722 Deletion mutant of mc2155 in 
which MSMEG4722 is replaced by hyg 
(Bhatt et al., 2008) 
ΔMSMEG4722-CRv ΔMSMEG4722 containing pMV261-
Rv2509 
(Bhatt et al., 2008) 
ΔMSMEG4722-
CNCgl2385 
ΔMSMEG4722 containing pMV261-
NCgl2385 
This work 
MSMEG4722-CRvD1 ΔMSMEG4722 containing pMV261-
Rv2509D1 
This work 
MSMEG4722-CRvD2 ΔMSMEG4722 containing pMV261-
Rv2509D2 
This work 
BCG::PTet-BCG2529 BCG Pasteur strain  containing the 
Pmyc1 promoter from M. smegmatis 
engineered to contain four tetO operator 
sites, inserted immediately upstream of 
the start codon of BCG2529, the BCG 
homologue of Rv2509. 
This work 
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